Alluti GmbH

Alluti GmbH

Bert Bleicher established Alluti GmbH in 2014 as an independent single-family office. The firm manages wealth generated from his role at the Hoffmann Group, a Munich-based industrial tools business where he served as managing partner before stepping down while retaining a shareholder position. Alluti operates from Seefeld with an address in Munich Bogenhausen and follows a mandate centered on patient capital deployment. The firm allocates across private equity, impact ventures, real estate and liquid assets. It participates in direct co-investments and SPVs rather than large fund-of-funds programs. Confirmed positions include Cansativa Group, where Alluti joined Casa Verde and Argonautic Ventures in the February 2022 Series B round, and PL BioScience, where it co-invested alongside Smart Invest, Jochen Tschunke and LSI Pre-Seed Fonds. Geographic reach spans Europe, North America, Asia and Oceania, with additional real-estate projects under development in Ulm and Freiburg. No public headcount or AUM figure exists. Bert Bleicher serves on the advisory board of Hettich Holding GmbH & Co. oHG alongside Georg Alexander Zeiss, Ralf Gärtner and members of the Hettich family. The firm lists one office asset at Schloss Seefeld and maintains relationships with entities such as Retla e.V. and the Hoffmann Group Foundation. No operational events from the last 24 months appear in available records. Alluti functions as a direct investor with co-investment partners rather than a multi-family platform or external fund manager. Its structure ties investment decisions to the founding principal's network from the Hoffmann Group era and ongoing advisory roles at other family-controlled industrial companies.